W0326
Structural Analysis of the Type I Nitroreductase From
Enterobacter Cloacae Reveals the Effects of Co-Factor Reduction and Substrate
Binding. Chad A. Haynes, Ronald L. Koder, Anne-Frances Miller, David W.
Rodgers, Molecular and Cellular Biochemistry, Univ. of Kentucky, Lexinton, KY
40536.
The type I nitroreductase (NR) enzyme from E. cloacae is
responsible for the NAD(P)H dependent reduction of nitroaromatic, quinone, and
riboflavin compounds. NR utilizes a tightly bound flavin mononucleotide (FMN)
molecule as the enzymatic co-factor. The enzyme displays broad substrate
specificity but reacts most readily with the explosive compounds
tri-nitrotoluene and di-nitrotoluene. We have pursued both biochemical and
structural studies of the enzyme in order to gain insight into the details of
the enzymatic mechanism, including both substrate binding and flavin chemistry.
In these studies, we have determined the crystal structures of oxidized NR bound
to two inhibitors, acetate and benzoate, as well as the substrate analogs
nicotinic acid adenine dinucleotide (NAAD) and para-nitrobenzoic acid (p-NBA).
Furthermore, we have determined the crystal structure of the two-electron
reduced enzyme.
The enzyme is a homodimer that adopts an a+b fold and binds
two flavin mononucleotide molecules at the dimer interface, creating two
independent active sites. The geometry of the flavin ring system is affected by
its redox state; the oxidized flavin is nonplanar, with an overall bend angle of
16∞; the bend angle increases to 25∞ in the reduced flavin. Since
free, oxidized flavin is planar in solution, the bend induced by binding to the
apo enzyme may thermodynamically encourage formation of the reduced flavin,
which is bent when free in solution. The conformation imposed on the bound
oxidized flavin may disfavor formation of the one-electron reduced or
semi-quinone state of the flavin, since it too, like the oxidized form, is
planar in solution.
Also, comparison between the two different competitive
inhibitor complexes shows that a portion of helix H6 can flex to accommodate the
differently sized inhibitors suggesting a mechanism for binding a variety of
substrates of differing sizes.
We will also report on the binding details of the NADH analog,
NAAD, and the second half reaction substrate p-NBA. General features including
positioning of the small molecules within the active site along with the
concomitant expansion of the active site will be presented.